Free Trial

Tango Therapeutics (TNGX) Stock Forecast & Price Target

Tango Therapeutics logo
$25.77 +1.47 (+6.04%)
As of 12:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tango Therapeutics - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
2
Buy
13

Based on 17 Wall Street analysts who have issued ratings for Tango Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 2 have given a sell rating, 2 have given a hold rating, and 13 have given a buy rating for TNGX.

Consensus Price Target

$45.54
77.10% Upside
According to the 17 analysts' twelve-month price targets for Tango Therapeutics, the average price target is $45.54. The highest price target for TNGX is $69.00, while the lowest price target for TNGX is $14.00. The average price target represents a forecasted upside of 77.10% from the current price of $25.71.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for TNGX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TNGX Analyst Ratings Over Time

TypeCurrent Forecast
11/11/25 to 11/11/26
1 Month Ago
10/12/25 to 10/12/26
3 Months Ago
8/13/25 to 8/13/26
1 Year Ago
11/11/24 to 11/11/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
13 Buy rating(s)
5 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$45.54$43.46$43.31$11.00
Forecasted Upside77.10% Upside79.82% Upside68.84% Upside31.26% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

TNGX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TNGX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Tango Therapeutics Stock vs. The Competition

TypeTango TherapeuticsHealthcare CompaniesBroader Market
Consensus Rating Score
2.65
2.32
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside87.40% Upside111.11% Upside14.55% Upside
News Sentiment Rating
Neutral News

See Recent TNGX News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/10/2026
Maury Raycroft
4 of 5 stars
Reiterated RatingBuy$65.00+165.37%
11/10/2026
Brian Cheng
Brian Cheng
5 of 5 stars
Boost TargetOverweight$46.00 ➝ $47.00+99.35%
11/10/2026
Wedbush logo
Wedbush
5 of 5 stars
Robert Driscoll
Robert Driscoll
5 of 5 stars
Lower TargetOutperform$45.00 ➝ $40.00+69.05%
11/10/2026Lower TargetBuy$68.00 ➝ $67.00+194.63%
11/4/2026 Reiterated RatingSell (D-)
10/27/2026 DowngradeHold ➝ Strong Sell
10/23/2026Set Target$55.00+129.86%
10/16/2026Initiated CoverageOutperform
8/12/2026Boost TargetBuy$32.00 ➝ $35.00+32.88%
7/17/2026Boost TargetOutperform$36.00 ➝ $40.00+40.08%
6/29/2026Boost TargetBuy$42.00 ➝ $46.00+43.78%
6/25/2026 DowngradeHold
6/8/2026 Set TargetPeer Perform ➝ Outperform$35.00+12.74%
6/8/2026 Reiterated RatingBuy
6/8/2026Boost TargetOutperform$55.00 ➝ $69.00+116.62%
5/14/2026DowngradeOverweight ➝ Neutral$16.00 ➝ $24.00-3.50%
5/14/2026 Set Target$55.00+121.15%
4/27/2026 Reiterated RatingBuy
10/27/2025 Reiterated RatingOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:12 PM ET.


TNGX Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Tango Therapeutics is $45.54, with a high forecast of $69.00 and a low forecast of $14.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tango Therapeutics in the last year. There are currently 2 sell ratings, 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TNGX shares.

According to analysts, Tango Therapeutics's stock has a predicted upside of 77.10% based on their 12-month stock forecasts.

Over the previous 90 days, Tango Therapeutics's stock had 1 downgrade by analysts.

Tango Therapeutics has been rated by research analysts at HC Wainwright, Jefferies Financial Group, JPMorgan Chase & Co., Stifel Nicolaus, Wedbush, Weiss Ratings, William Blair, and Zacks Research in the past 90 days.

Analysts like Tango Therapeutics more than other "healthcare" companies. The consensus rating for Tango Therapeutics is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how TNGX compares to other companies.


MarketBeat monitors more than a dozen sources for Tango Therapeutics analyst ratings, with the most recent rating issued on 11/10/2026.
From Our Partners